Proquad vials
Ended Awarded Last action
- Contract number
- SPE2DR26F3N6J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,539
Award facts
- Contract value 100% obligated
- $6,538.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,538.68 to AmerisourceBergen Drug Corp for ProQuad vials on November 26, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle that extends through December 2026. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, reflecting the essential pharmaceutical and medical supply support that AmerisourceBergen provides to military healthcare systems and the broader federal medical supply chain.
As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a critical vendor for federal military and veteran healthcare procurement. The company's extensive federal contract portfolio with DLA demonstrates its capability to supply comprehensive pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order is one of numerous small-to-medium value transactions executed under the larger SPE2DX indefinite delivery contract, showcasing AmerisourceBergen's role in supporting the Defense Health Agency and other government healthcare entities with reliable access to pharmaceutical commodities needed for military medical operations.
Quick answers
Who was awarded contract SPE2DR26F3N6J?
SPE2DR26F3N6J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26F3N6J worth?
The government has obligated $6,539 on SPE2DR26F3N6J.
Is contract SPE2DR26F3N6J an order under another contract?
Yes. SPE2DR26F3N6J is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3N6J competed?
The extent of competition for SPE2DR26F3N6J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award